Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3377811 | 0.76 | — | — | |
| SCHEMBL3375575 | 0.75 | — | — | |
| SCHEMBL7039669 | 0.74 | CA2 (0.34) | — | |
| SCHEMBL5029451 | 0.73 | ALDH1A1 (0.30) | — | |
| SCHEMBL1451515 | 0.73 | ALDH1A1 (0.30) | — | |
| SCHEMBL31536925 | 0.73 | ALDH1A1 (0.30) | — | |
| SCHEMBL1454519 | 0.73 | HTR2C (0.31) | — | |
| SCHEMBL8369933 | 0.72 | IDO1 (0.30) | — | |
| SCHEMBL1453433 | 0.70 | — | — | |
| SCHEMBL1452420 | 0.70 | ACHE (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1401880-B1 | METALLOCENE CATALYSTS CONTAINING AN INDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP | BOREALIS TECH OY (FI) | 2010-11-10 | — | — | EP | disclosed |
| US-7074863-B2 | Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group | BOREALIS TECHNOLOGY OY (FI) | 2006-07-11 | — | — | US | disclosed |
| US-20040152882-A1 | Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group | BOREALIS TECHNOLOGY OY (FI) | 2004-08-05 | — | — | US | disclosed |
| EP-1401880-A1 | METALLOCENE CATALYSTS CONTAINING AN INDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP | Borealis Technology Oy (FI) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003000744-A1 | METALLOCENE CATALYSTS CONTAINING AN IDENYL MOIETY SUBSTITUTED AT THE 4-, 5-, 6- OR 7-POSITION BY A SILOXY OR GERMYLOXY GROUP | BOREALIS TECHNOLOGY OY (FI) | 2003-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152882-A1 | Metallocene catalysts containing an idenyl moiety substituted at the 4,-5,-6- or 7-position by a siloxy or germyloxy group | IPO4, GEMIN4, GEMIN5 | DRD2 3702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.